It is observed that in hormone refractory or androgen-independent (AI) prostate cancer cells, a large pool of androgen receptor is translocated into the nucleus even in the absence of androgen and thus leads to the transcriptional activation of target genes resulting in tumor growth (11, 12). The gene discussed is AR; the disease is prostate carcinoma.